SRPT today
$16.68+$0.26 (+1.58%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourExpanding
1 hourStrong Bearish
15 minBearish
5 minStrong Bullish
Daily trend turns up above $24.68
Key levels
Resistance$19.28
Resistance$18.10
Support$16.37
Support$14.75
Latest news & SEC filings
AnalystDeutsche Bank raises Sarepta Therapeutics rating to Hold
AnalystRBC Lifts Its Target Price for Sarepta Therapeutics
AnalystRBC Capital keeps Sector Perform on Sarepta Therapeutics, lifts price target to $18
All SRPT news →About Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company focused on precision genetic medicines for rare neuromuscular diseases. Its marketed products include exon-skipping therapies for Duchenne muscular dystrophy and a gene therapy for Duchenne, along with development programs in limb-girdle muscular dystrophies and other muscle disorders. It sells mainly in the United States, with some products available in selected other countries and through an early access program, and it partners with Roche for the gene therapy outside the U.S.
Based on the company's 10-K filed Mar 2, 2026.
Nasdaq · Healthcare
Sarepta Therapeutics, Inc. (SRPT)
What Is the Price Target for SRPT?
SEPT Low Target
$5.00
SEPT Mid Target
$18.50
SEPT High Target
$27.00
Analyst Consensus
$18.50
Is SRPT a Buy or Sell Right Now?
Thesis
- •Revenue growing 15.6% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SRPT.
Start Free Trial →Is SRPT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$28.12
15
Moat Score
NONE
3/9
Piotroski Score
-1.1
Altman Z-Score
What Is Smart Money Doing with SRPT?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SRPT Growth Story
Revenue YoY
15.6%
3yr Revenue CAGR
33.1%
EPS Growth YoY
-404.7%
FCF Growth YoY
-62.0%
Revenue Trend
STRONG
Dark Pool Trades for SRPT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SRPT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:57:56 | $16.68 | 51,022 | $$851K | SELL |
| 21:00:45 | $16.68 | 2,196 | $$37K | BUY |
| 21:00:09 | $16.68 | 2,600 | $$43K | BUY |
| 21:00:09 | $16.68 | 11,223 | $$187K | BUY |
| 21:00:09 | $16.68 | 6,171 | $$103K | BUY |
5 dark pool trades shown · $$1.2M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for SRPT
PREVIEWSEPT Investing provides real-time options flow tracking for SRPT, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| CALL | $20 | Nov 20 | 9 | $$60 | 6 | SWEEP |
| CALL | $20 | Jun 17 | 218 | $$620 | 2 | SWEEP |
| CALL | $20 | Jun 17 | 218 | $$620 | 2 | SWEEP |
| CALL | $20 | Jun 17 | 218 | $$1240 | 4 | SWEEP |
| CALL | $20 | Jun 17 | 218 | $$310 | 1 | SWEEP |
5 options trades shown · 100% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Sarepta Therapeutics, Inc. (SRPT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SRPT — frequently asked questions
What is SRPT stock price today?
Sarepta Therapeutics, Inc. (SRPT) is at $16.68, up 1.58% (+$0.26) at the Nov 11, 2026 close.
Why is SRPT stock moving today?
Latest SRPT news — Nov 10, 2026: Deutsche Bank raises Sarepta Therapeutics rating to Hold · Nov 6, 2026: RBC Lifts Its Target Price for Sarepta Therapeutics
What is the SRPT price target?
The average analyst price target for SRPT is $18.50, ranging from $5 to $27, based on 6 analysts. Latest: RBC Capital maintains on Oct 8, 2026.
What do analysts rate SRPT?
Analyst ratings for SRPT: 1 Buy, 8 Hold, 0 Sell — consensus Hold.
Does SRPT pay a dividend?
SRPT does not currently pay a dividend.
How much debt does SRPT have?
Sarepta Therapeutics, Inc. reported $848M of debt and $571M of cash (Jun 30, 2026).
What are SRPT support and resistance levels?
Support: $16.37, $14.75. Resistance: $18.10, $19.28, $20.88.
What are insiders doing with SRPT?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on SRPT?
Nov 10, 2026: Deutsche Bank raises Sarepta Therapeutics rating to Hold · Nov 6, 2026: RBC Lifts Its Target Price for Sarepta Therapeutics · Nov 6, 2026: RBC Capital keeps Sector Perform on Sarepta Therapeutics, lifts price target to $18